The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPantheon Res Regulatory News (PANR)

Share Price Information for Pantheon Res (PANR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.20
Bid: 32.20
Ask: 32.55
Change: -0.55 (-1.68%)
Spread: 0.35 (1.087%)
Open: 32.75
High: 32.75
Low: 32.20
Prev. Close: 32.75
PANR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issuance of Share Options to Directors and staff

7 Jul 2020 07:00

RNS Number : 1860S
Pantheon Resources PLC
07 July 2020
 

 

 

7 July, 2020

 

Pantheon Resources plc

Issuance of Share Options to Directors and staff

 

 

Pantheon Resources plc ("Pantheon" or "the Company"), the AIM-quoted oil and gas exploration company with 89.2% - 100% working interests in several projects on the Alaskan North Slope, and 58% - 100% working interests in projects in Polk & Tyler Counties, East Texas, announces the grant of share options (the"Grant") under the updated Pantheon Resources plc 2009 Discretionary Share Option Plan ("Scheme").

 

The Board has been advised by the expert remuneration consultants at Deloitte LLP who have provided guidance on the structuring of the Scheme with the objective of providing an appropriate performance based incentive for all participants, and which also aligns with the Company's strategy to create material value for its stakeholders through its oil exploration, appraisal and development activities. The updated Share Option Plan covers all staff and is comprised of two components; a grant of premium priced share options (today) as detailed in this announcement, together with provision for future annual grants based upon performance where the timing, amounts and vestings conditions of any such future grants would depend upon the circumstances prevailing at that time. Under the terms of the Scheme, total share options are limited to a maximum 15 per cent. of the Company's issued share capital in any 10 year rolling period. All options are subject to defined malus and clawback provisions.  The Grant represents the first issuance of share options to staff since 2014.

 

Today's award of share options will have an exercise price of £0.27, representing a premium of 93% to the closing share price of £0.14 yesterday. 50% of the share options granted today will vest 90 days from today's date, and the remaining 50% will vest upon the spudding of the next well on the Company's Alaskan acreage.

 

The Grant to all Executive Directors, certain consultants and employees of the Company have been made under the Share Option Scheme or pursuant to option agreements.

 

Details of the awards to Directors and PDMRs are presented in the following table:

 

Director

Number of options granted2

Exercise Price 

per Share option

Options as a per cent of issued Share Capital following the Placing1

John Cheatham

1,500,000

27 pence

0.25%

Robert Rosenthal

1,500,000

27 pence

0.25%

Justin Hondris

1,500,000

27 pence

0.25%

1. Issued share capital includes all voting shares and 102.4m non-voting shares.

2. Terms: £0.27 exercise price, 10 year life and vest in 2 equal tranches; 50% subject to a time based condition (90 days from grant) and 50% subject to a performance milestone (spudding of the next well in Alaska).

 

 

 

 

The table below discloses all share options attributable to the Directors and PDMR's following the granting of these share options:

 

Director

Number of share options granted today

Number of pre-existing share options, issued in 2014 (£0.30 exercise price, Sept 2024 expiry)2

Options as a per cent of issued Share Capital following the Placing1

Phillip Gobe

-

-

-

John Cheatham

1,500,000

4,385,000

0.97%

Robert Rosenthal

1,500,000

-

0.25%

Justin Hondris

1,500,000

3,865,000

0.89%

Jeremy Brest

-

-

-

1. Issued share capital includes all voting shares and 102.4m non-voting shares

2. Share options issued in 2014

 

 

The transaction notifications for each PDMR can be found at the bottom of this RNS. This notice is given in fulfilment of the obligation under Article 19 of the Market Abuse Regulation.

 

Related Party Transaction

The Share Option Scheme, and the award to the Executive Directors is a Related Party transaction pursuant to the AIM Rules for Companies. Accordingly the non-executive Directors, who are independent, consider, having consulted with the Company's Nominated Adviser, that the terms of the Share Option Scheme and the award to the Executive Directors is fair and reasonable in so far as shareholders are concerned.

 

Phillip Gobe, Chairman stated:

"I am pleased to implement our long-awaited staff share option scheme which includes each and every one of our 16 employees and consultants. I am very proud of our team's fantastic achievements over the past 18 months and it was of great importance to me that we established this scheme to allow them to benefit from future success.

 

"Astute shareholders will note the 27p exercise price is a huge premium to the current share price, meaning that shareholders will enjoy a c.90% share price uplift before these share options have any value to our staff at all. The pricing is a clear motivator for significant future achievement. Additionally, half of the share options will only vest upon the spudding of the next Alaskan well, aligning the interests of all staff with those of shareholders, and providing motivation and urgency to achieve drilling as soon as possible. We believe our acreage has tremendous potential for value creation and our share option scheme allows staff to benefit from this, but crucially, only after shareholders."

 

Further information:

 

Pantheon Resources plc

+44 20 7484 5361

Jay Cheatham, CEO

 

Justin Hondris, Director, Finance and Corporate Development

 

 

 

 

 

 

Arden Partners plc (Nominated Adviser and broker)

+44 20 7614 5900

Paul Shackleton / Daniel Gee-Summons (Corporate Finance)

Simon Johnson (Equity Sales)

 

 

 

Blytheweigh

+44 20 7138 3204

Tim Blythe, Megan Ray

 

 

 

Notes to Editors

Pantheon Resources plc is an AIM listed Oil & Gas exploration and production company with assets in East Texas and on the North Slope of Alaska, onshore USA. The Group's stated objective is to create material value for its stakeholders through oil exploration, appraisal and development activities in high impact, highly prospective conventional assets, in the USA; a highly established region for energy production with infrastructure, skilled personnel and low sovereign risk. All operations are onshore USA, with drilling costs materially below that of offshore wells.

 

On the North Slope of Alaska, Pantheon holds working interests of 89.2% - 100% in projects covering c.180,000 gross acres, covered by c.1,000 square miles of proprietary 3D seismic. In January 2020 the Company received an Independent Expert Report certifying a Contingent Resource of 76.5MMBO (million barrels of oil) recoverable on its Greater Alkaid project. In March 2020 Pantheon estimated that the shallowest of the 3 horizons at its Talitha project was estimated to contain 1.8 billion barrels of oil in place and a P50 Technically Recoverable Resource of 483 MMBO. In East Texas, Pantheon has working interests in several conventional prospects in Tyler & Polk Counties, in an area of abundant regional infrastructure.

 

For further information on Pantheon Resources plc, see the website at: www.pantheonresources.com.The information contained within this RNS is considered to be inside information prior to its release. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

(1) John (Jay) Cheatham

(2) Robert Rosenthal

(3) Justin Hondris

2

Reason for the notification

a)

Position/status

(1) CEO

(2) Technical Director

(3) Finance Director

b) 

Initial notification /Amendment 

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Pantheon Resources plc

b)

LEI

 213800SWHY5DNQS64J23

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Option over Ordinary Shares of £0.01 

b)

 

Nature of the transaction

Option over Ordinary Shares

 

c)

 

Price(s) and volume(s)

 

(1) 1,500,000 options to acquire ordinary shares at an exercise price of £0.27 per share

(2) 1,500,000 options to acquire ordinary shares at an exercise price of £0.27 per share

(3) 1,500,000 options to acquire ordinary shares at an exercise price of £0.27 per share

 

d)

 

Aggregated information

· Aggregated volume

· Price

 N/A

e)

 

Date of the transaction

7 July, 2020

f)

Place of the transaction

 Outside a trading venue

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHGZGGNGVFGGZZ
Date   Source Headline
24th Apr 20247:00 amRNSTR-1: Notification of major holdings
10th Apr 20244:53 pmRNSWebinar and update
9th Apr 20247:00 amRNSKodiak resource upgraded to 1.2 billion barrels
2nd Apr 20244:30 pmRNSDirector/PDMR Notification
28th Mar 20247:05 amRNSProgress on Funding and Development Planning
21st Mar 202411:51 amRNSTR-1: Notification of major holdings
18th Mar 20247:00 amRNSUnaudited Interim Results
14th Mar 20247:00 amRNSQuarterly Repayment of Unsecured Convertible Bonds
5th Mar 20245:05 pmRNSResponse to Share Price Volatility
2nd Feb 20247:00 amRNSTR-1: Notification of major holdings
1st Feb 20247:00 amRNSDirector/PDMR notification
24th Jan 20243:15 pmRNSResult of AGM & Investor Presentation Details
23rd Jan 20247:00 amRNSAnnual General Meeting
2nd Jan 20247:00 amRNSTR-1: Notification of major holdings
19th Dec 20237:00 amRNSFinal Results for the Year Ended 30 June 2023
14th Dec 20237:04 amRNSSuccessful Acquisition of Leases
12th Dec 20237:00 amRNSAppointment of Independent Non-Executive Director
21st Nov 20234:36 pmRNSStrategy Update
15th Nov 20231:54 pmRNSInvestor Presentation via Investor Meet Company
14th Nov 202311:56 amRNSBond Payment, Placement & Corporate Update
19th Oct 20237:00 amRNSValidation of frac design and fluid sampling
18th Oct 20237:00 amRNSPantheon Presenting at OTC Oil and Gas Conference
4th Oct 20237:00 amRNSReplacement TR-1: Notification of major holdings
3rd Oct 20234:02 pmRNSTR-1: Notification of major holdings
27th Sep 20237:00 amRNSCommencement of Operations - Re-entry of Alkaid-2
14th Sep 20233:34 pmRNSWebinar and update
8th Sep 20238:20 amRNSInvestor Presentation Webinar
7th Sep 20237:00 amRNSPrivate Placement
30th Aug 20237:00 amRNSDirector/PDMR Notification
29th Aug 20237:00 amRNSExpert Report Confirms Estimate for Kodiak Field
28th Jul 20237:57 amRNSReplacement Operational Update
28th Jul 20237:00 amRNSOperational Update
14th Jul 20239:30 amRNSInvestor Presentation via Investor Meet Company
10th Jul 20237:00 amRNSInvestor Presentation via Investor Meet Company
3rd Jul 20238:53 amRNSAppointment of Independent Non-Executive Director
28th Jun 20234:58 pmRNSWebinar and Strategy Update
26th Jun 202312:54 pmRNSUpcoming Webinar - Registration Details
15th Jun 20233:50 pmRNSIssue of Equity and Total Voting Rights
8th Jun 20237:00 amRNSAppointment of Executive Chairman
1st Jun 20237:00 amRNSLease Award
23rd May 20234:32 pmRNSUpdate on Fundraise
18th May 20235:40 pmRNSBlock Listing Six Monthly return
17th May 20237:00 amRNSResult of Capital Raise
16th May 20235:07 pmRNSRetail Offer via PrimaryBid
16th May 20234:59 pmRNSProposed Placing and Subscription
21st Apr 20237:00 amRNSOperational and corporate update
31st Mar 20237:00 amRNSUnaudited Interim Results
22nd Mar 20235:09 pmRNSResult of AGM
20th Mar 20234:45 pmRNSAGM update
20th Mar 20237:00 amRNSAGM webinar & corporate update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.